Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1951 4
1952 3
1953 3
1954 1
1955 4
1956 3
1957 2
1958 4
1959 1
1966 1
1967 4
1969 2
1970 4
1971 2
1973 4
1974 4
1975 1
1976 3
1978 2
1979 3
1980 1
1981 3
1982 3
1983 2
1984 1
1985 6
1986 3
1987 1
1988 1
1989 3
1990 2
1991 1
1992 1
1993 3
1994 6
1995 8
1996 7
1997 9
1998 15
1999 11
2000 17
2001 13
2002 5
2003 1
2005 2
2006 2
2007 2
2008 5
2009 8
2010 7
2011 2
2012 1
2013 7
2014 6
2015 9
2016 7
2017 13
2018 5
2019 10
2020 11
2021 6
2022 10
2023 4
2024 13
2025 10
2026 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

312 results

Results by year

Filters applied: . Clear all
Page 1
A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection.
Mayer KA, Schrezenmeier E, Diebold M, Halloran PF, Schatzl M, Schranz S, Haindl S, Kasbohm S, Kainz A, Eskandary F, Doberer K, Patel UD, Dudani JS, Regele H, Kozakowski N, Kläger J, Boxhammer R, Amann K, Puchhammer-Stöckl E, Vietzen H, Beck J, Schütz E, Akifova A, Firbas C, Gilbert HN, Osmanodja B, Halleck F, Jilma B, Budde K, Böhmig GA. Mayer KA, et al. Among authors: schutz e. N Engl J Med. 2024 Jul 11;391(2):122-132. doi: 10.1056/NEJMoa2400763. Epub 2024 May 25. N Engl J Med. 2024. PMID: 38804514 Clinical Trial.
Donor-derived cell-free DNA monitoring for early diagnosis of antibody-mediated rejection after kidney transplantation: a randomized trial.
Akifova A, Budde K, Amann K, Buettner-Herold M, Choi M, Oellerich M, Beck J, Bornemann-Kolatzki K, Schütz E, Bachmann F, Halleck F, von Hoerschelmann E, Koch N, Schrezenmeier E, Seelow E, Waiser J, Zukunft B, Eckardt KU, Halbritter J, Kettritz R, Del Moral CL, Lachmann N, Stauch D, Niemann M, Schmidt D, Halloran PF, Osmanodja B. Akifova A, et al. Among authors: schutz e. Nephrol Dial Transplant. 2025 Jun 30;40(7):1384-1395. doi: 10.1093/ndt/gfae282. Nephrol Dial Transplant. 2025. PMID: 39673311 Free PMC article. Clinical Trial.
Toxicology of clobazam.
Schütz E. Schütz E. Br J Clin Pharmacol. 1979;7 Suppl 1(Suppl 1):33S-35S. doi: 10.1111/j.1365-2125.1979.tb04662.x. Br J Clin Pharmacol. 1979. PMID: 35202 Free PMC article.
Cachexia in liver cirrhosis.
Plauth M, Schütz ET. Plauth M, et al. Among authors: schutz et. Int J Cardiol. 2002 Sep;85(1):83-7. doi: 10.1016/s0167-5273(02)00236-x. Int J Cardiol. 2002. PMID: 12163212 Review.
Association of Blood Donor-derived Cell-free DNA Levels With Banff Scores and Histopathological Lesions in Kidney Allograft Biopsies: Results From an Observational Study.
Akifova A, Budde K, Choi M, Amann K, Buettner-Herold M, Oellerich M, Beck J, Bornemann-Kolatzki K, Schütz E, Bachmann F, Halleck F, Schrezenmeier EV, Seelow E, Zukunft B, Hammett C, Pohl NA, Mordà B, Kowald J, Lachmann N, Stauch D, Osmanodja B. Akifova A, et al. Among authors: schutz e. Transplant Direct. 2025 Apr 10;11(5):e1794. doi: 10.1097/TXD.0000000000001794. eCollection 2025 May. Transplant Direct. 2025. PMID: 40746944 Free PMC article.
Prolonged CD38 targeting with felzartamab in antibody-mediated kidney transplant rejection: a biomarker-guided open-label phase 2 extension.
Mayer KA, Diebold M, Schrezenmeier EV, Halloran PF, Haindl S, Schatzl M, Akifova A, Allmer DM, Schranz S, Kozakowski N, Kläger J, Amann K, Beck J, Schütz E, Naesens M, Loupy A, Raynaud M, Görzer I, Vietzen H, Ingle G, Flesher DL, Patel UD, Halleck F, Graf I, Jilma B, Budde K, Böhmig GA. Mayer KA, et al. Among authors: schutz e. Lancet Reg Health Eur. 2026 Jul 9;68:101768. doi: 10.1016/j.lanepe.2026.101768. eCollection 2026 Sep. Lancet Reg Health Eur. 2026. PMID: 42471965 Free PMC article.
Emphysematous pyelonephritis caused by C. glabrata.
Schutz EA, Zabott AP, Boaretto RBB, Toyama G, Morais CF, Moroni JG, Oliveira CS. Schutz EA, et al. J Bras Nefrol. 2022 Jul-Sep;44(3):447-451. doi: 10.1590/2175-8239-JBN-2020-0184. J Bras Nefrol. 2022. PMID: 33760910 Free PMC article.
A multicenter registry study of the CD38 antibody daratumumab for the treatment of microvascular inflammation following kidney transplantation.
Drasch T, Mayer KA, Böhmig GA, Akifova A, Halleck F, Budde K, Rohlfing D, Hinze C, Kluger M, Grahammer F, Kowald J, Baatz S, Reuter S, Kemmner S, Seibt T, Pigorsch M, Beck J, Bornemann-Kolatzki K, Schütz E, Oellerich M, Banas B, Zecher D. Drasch T, et al. Among authors: schutz e. Kidney Int. 2026 Jul 23:S0085-2538(26)00604-6. doi: 10.1016/j.kint.2026.06.033. Online ahead of print. Kidney Int. 2026. PMID: 42492852 Free article.
Endothelial cell senescence and thrombosis: Ageing clots.
Bochenek ML, Schütz E, Schäfer K. Bochenek ML, et al. Among authors: schutz e. Thromb Res. 2016 Nov;147:36-45. doi: 10.1016/j.thromres.2016.09.019. Epub 2016 Sep 20. Thromb Res. 2016. PMID: 27669126 Review.
312 results